PATENT CLAIM ANALYSIS

Application Number: 16040981
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
The disclosure relates to respiratory virus ribonucleic acid (RNA) vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 159):
The method of  claim 136 , wherein the isolated mRNA polynucleotide of (b) comprises an open reading frame that comprises a nucleotide sequence that has at least 90% identity to the RNA sequence identified by SEQ ID NO: 57.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15674599', '15674591', '15674585', '15674569', '16006526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8628600396010999
- 35 USC 102 Novelty (BERT): 0.796593918996373
- Combined Prediction Score: 0.8562334275406273
- Mean Citation Score: 760.816598
- Max Citation Score: 1268.1471
- Similarity Product: 1024.055244907093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test